ArticleNeoplasia (New York, N.Y.)2021

Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia.

So Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.